生血宁片联合乳酸亚铁片治疗妊娠期缺铁性贫血临床研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R556.3

基金项目:


Clinical Study on Curative Effect of Shengxuening Tablets Combined with Ferrous Lactate Tablets on Iron Deficiency Anemia During Pregnancy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察生血宁片联合乳酸亚铁片治疗妊娠期缺铁性贫血(IDA) 的临床疗效。方法:选取 120 例妊娠期IDA患者为研究对象,按随机数字表法分为观察组与对照组各60例。对照组给予乳酸亚铁片治 疗,观察组给予生血宁片联合乳酸亚铁片治疗。2组均以1周为1个疗程,4个疗程后比较2组临床疗效、中医 证候评分、血常规指标[血红蛋白(Hb)、红细胞(RBC)、平均红细胞体积(MCV) ]及铁代谢指标[血清铁蛋 白(SF)、血清铁(SI)、转铁蛋白饱和度(TSAT) ]水平。结果:治疗后,观察组总有效率为95.00%,对照组 为80.00%,2组比较,差异有统计学意义(P<0.05)。治疗后,2组面色萎黄、心悸气短、头晕眼花、神疲乏 力、手足麻木、懒言、自汗等中医证候评分均较治疗前降低(P<0.05),且观察组上述各项评分均低于对照 组(P<0.05)。治疗后,2组RBC、Hb、MCV水平均较治疗前升高(P<0.05),且观察组RBC、Hb、MCV水 平均高于对照组(P<0.05)。治疗后,2 组SI、TSAT、SF 水平均较治疗前升高(P<0.05),且观察组SI、 TSAT、SF水平均高于对照组(P<0.05)。结论:生血宁片联合乳酸亚铁片治疗妊娠期IDA可有效促进机体铁 代谢,有利于提高临床疗效,减轻临床症状,纠正贫血状态。

    Abstract:

    Abstract: Objective: To observe the curative effect of Shengxuening Tablets combined with Ferrous Lactate Tablets on iron deficiency anemia (IDA) during pregnancy. Methods:A total of 120 pregnant women with IDA were selected as the study subjects and divided into the observation group and the control group according to the random number table method,with 60 cases in each group. The control group was treated with Ferrous Lactate Tablets, and the observation group was treated with Shengxuening Tablets and Ferrous Lactate Tablets. Both groups were treated for four courses, with one week as a course of treatment. After four courses, the clinical effects, traditional Chinese medicine (TCM) syndrome scores, and the levels of blood routine indexes [hemoglobin (Hb), red blood cell (RBC), and mean corpuscular volume (MCV)], and iron metabolism indexes [serum ferritin (SF), serum iron (SI), and transferrin saturation (TSAT)] were compared between the two groups. Results: After treatment, the total effective rate was 95.00% in the observation group, and 80.00% in the control group, the difference being significant (P<0.05). After treatment,the scores of TCM syndromes such as pale complexion,palpitations and shortness of breath,dizziness and vertigo,fatigue and lack of strength,numbness in hands and feet, lazy speech, and spontaneous sweating in the two groups were decreased when compared with those before treatment (P<0.05), and the above scores in the observation group were lower than those in the control group (P<0.05). After treatment, the levels of RBC, Hb, and MCV in the two groups were increased when compared with those before treatment (P<0.05),and the levels of RBC,Hb,and MCV in the observation group were higher than those in the control group (P<0.05). After treatment,the levels of SI, TSAT, and SF in the two groups were increased when compared with those before treatment (P< 0.05),and the levels of SI,TSAT,and SF in the observation group were higher than those in the control group (P<0.05). Conclusion:Shengxuening Tablets combined with Ferrous Lactate Tablets for IDA during pregnancy is beneficial for promoting iron metabolism, improving clinical effects, reducing clinical symptoms,and correcting anemia.

    参考文献
    相似文献
    引证文献
引用本文

蒋云云.生血宁片联合乳酸亚铁片治疗妊娠期缺铁性贫血临床研究[J].新中医,2024,56(10):91-95

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-05-28
  • 出版日期: